Log in to search using one of your social media accounts:

 

Rapid radiation therapy minimizes treatment time, improves quality of life
Faster treatment is possible for a variety of cancers, thanks to hypofractionated radiotherapy currently being employed by doctors at Yale Medicine. (Source: Yale Science and Health News)
Source: Yale Science and Health News - February 15, 2018 Category: Universities & Medical Training Source Type: news

Only U.S. Cryotherapy Trial for Mesothelioma Finds Success
Thoracic surgeon Dr. Shanda Blackmon at the Mayo Clinic in Rochester, Minnesota, believes there is a place for cryotherapy in the future multidisciplinary treatment of pleural mesothelioma. She wants to show it with this groundbreaking clinical trial. “We think [cryotherapy] could play an important role in treatment,” Blackmon told Asbestos.com. “So far, things look promising, but you can’t say anything specific without more numbers. Right now, it’s a little like telling a story.” Cryotherapy involves destroying cancer cells, or any abnormal tissues, by freezing them with controlled nitr...
Source: Asbestos and Mesothelioma News - February 14, 2018 Category: Environmental Health Authors: Daniel King Tags: ADI-PEG 20 cryoablation cryotherapy intrapleural measles virus Mayo Clinic mesothelioma clinical trial Opdivo pacific mesothelioma center pleural mesothelioma pleuroscopy Shanda Blackmon Surgery for Mesothelioma After Radiation Thera Source Type: news

Nivolumab immunotherapy safe, feasible during chemoradiation for adv. head and neck cancer
(American Society for Radiation Oncology) Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiation therapy and chemotherapy for patients with newly diagnosed local-regionally advanced head and neck cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2018 Category: International Medicine & Public Health Source Type: news

India clears Varian's Halcyon radiation therapy system
Varian Medical Systems' Halcyon radiation therapy system has received the Atomic...Read more on AuntMinnie.comRelated Reading: Varian acquires Mobius Medical Varian inks deal to acquire Sirtex for $1.3B Varian posts double-digit Q1 gain Varian pursues partnership in China Taiwan clears Varian's radiation therapy system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 6, 2018 Category: Radiology Source Type: news

VCU scientists seek to perfect calculations for comparing cervical cancer radiation doses
(Virginia Commonwealth University) Research from VCU Massey Cancer Center has found that one of the standard practices for comparing cervical cancer radiation therapy treatments may be misleading, and the use of an alternative mathematical formula could be used to more effectively predict and potentially improve outcomes for patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2018 Category: International Medicine & Public Health Source Type: news

Adding crizotinib to radiation therapy may help preserve hearing in patients with NF2
(Massachusetts General Hospital) A Massachusetts General Hospital research team reports that the use of crizotinib to block a specific molecular pathway both enhanced the radiosensitivity of tumors in mouse models of NF2, allowing a reduction in radiation dosage, and inhibited the growth of cultured tumor cells from NF2 patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 5, 2018 Category: Cancer & Oncology Source Type: news

Why Do Physicians Overtreat Elderly Breast Cancer Patients? Why Do Physicians Overtreat Elderly Breast Cancer Patients?
Drs Kathy Miller and Reshma Jagsi on the reasons behind practitioners'reluctance to omit radiation therapy in older patients.Medscape Oncology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 1, 2018 Category: Radiology Tags: Hematology-Oncology Commentary Source Type: news

PSMA PET/CT visualizes prostate cancer recurrence early, impacts radiation therapy
(Society of Nuclear Medicine and Molecular Imaging) A nuclear medicine scan may locate prostate cancer recurrence after radical prostatectomy early after disease recurrence and could help guide salvage radiotherapy, according to new research from the University of California Los Angeles (UCLA). The study, which utilizes PET/CT with gallium-68 prostate-specific membrane antigen (68Ga-PSMA-11), is documented in the featured article in the February issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2018 Category: International Medicine & Public Health Source Type: news

Varian to Acquire Embattled Sirtex for $1.3B
Varian Medical Systems has revealed plans to acquire interventional oncology specialist Sirtex Medical for $1.3 billion. The proposed acquisition comes about a year after the New South Wales, Australia-based company fired CEO Gilman Wong, following an investigation into his share trading. In January 2017, the Sydney Morning Herald reported Wong was terminated after an investigation revealed he received $2.1 million from the sale of shares in Sirtex about one day after he told investors at the company’s annual general meeting that the company expected “double-digit” dose sales in 2017. Wong was replaced ...
Source: MDDI - February 1, 2018 Category: Medical Devices Authors: Omar Ford Tags: Medical Device Business Source Type: news

Elekta inks oncology co-selling deal with IBM Watson Health
Elekta (STO:EKTA B) said today it inked a collaborative sales deal with IBM‘s (NYSE:IBM) Watson Health through which Elekta will offer IBM’s Watson for Oncology with its cancer care solutions. With the deal, Elekta said it will begin offering the Watson for Oncology early this year as a clinical decision support solution paired with its digital cancer care solutions, including the Mosaiq oncology information systems. The combined offerings will be made available in markets including the US, Brazil, India, Australia and select European and Asian markets, Elekta said. “Joining forces with IBM Wats...
Source: Mass Device - January 31, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology Elekta IBM Watson Health Source Type: news

Microbubbles improve breast cancer radiation therapy
Injecting breast cancer with oxygen-filled microbubbles makes tumors three...Read more on AuntMinnie.comRelated Reading: ASTRO: Short radiation course safe for breast cancer LED device could predict skin damage from breast RT NEJM: RT boosts heart disease risk in breast cancer patients Robotic IMRT-APBI works well for breast cancer patients SABCS: Study links APBI to higher complication rates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 30, 2018 Category: Radiology Source Type: news

Varian inks deal to acquire Sirtex for $1.3B
Varian Medical Systems has agreed to acquire interventional oncology therapy...Read more on AuntMinnie.comRelated Reading: Varian posts double-digit Q1 gain Varian pursues partnership in China Taiwan clears Varian's radiation therapy system Sirtex highlights research on colorectal cancer survival Sirtex touts microsphere study at ASCO 2017 NCCN recommends Sirtex's microspheres (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 30, 2018 Category: Radiology Source Type: news

MRI scan volume drops in 2017, but new purchases planned
Bucking a consistently upward trend, the total number of MRI procedures in...Read more on AuntMinnie.comRelated Reading: IMV: Imaging sites happiest with mammo systems IMV: Technology drives radiation therapy market IMV: Hospital cardiology moving beyond CPACS, CVIS Report: MRI scanner installed base is long in the tooth Report: CT procedure volume drops 11% over past 2 years (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 30, 2018 Category: Radiology Source Type: news

New radiation techniques could improve quality of life for lung cancer patients
(Lawson Health Research Institute) While palliative radiation therapy is used to ease pain in patients with advanced lung cancer, it often has adverse effects on the esophagus which leads to symptoms like heartburn and difficulty swallowing. Through the PROACTIVE clinical trial, Lawson Health Research Institute scientist Dr. Alexander Louie is testing new palliative radiation techniques to spare these effects on the esophagus and improve quality of life for lung cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 29, 2018 Category: Cancer & Oncology Source Type: news

Microbubbles make breast cancer more susceptible to radiation therapy
(Thomas Jefferson University) Bursting oxygen-filled microbubbles in breast cancer makes tumors three times more sensitive to radiation therapy in preliminary tests with animal models of the disease (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2018 Category: International Medicine & Public Health Source Type: news

Varian posts double-digit Q1 gain
Powered by double-digit growth in its Oncology business segment, Varian Medical...Read more on AuntMinnie.comRelated Reading: Varian pursues partnership in China Taiwan clears Varian's radiation therapy system Varian's Halcyon receives Brazilian market clearance Oncology Services installs Varian radiotherapy system Varian opens new regional center in Brazil (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 25, 2018 Category: Radiology Source Type: news

ASCO Guideline Offers Recommendations for Management of Mesothelioma
ASCO recently released a clinical practice guideline on the treatment of malignant pleural mesothelioma, including recommendations on diagnosis, staging, and treatment with chemotherapy, surgical cytoreduction, and radiation therapy. (Source: CancerNetwork)
Source: CancerNetwork - January 24, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Lung Cancer Mesothelioma News Source Type: news

Accuray shares rise on FY2018 Q2 EPS beat
Shares in Accuray (NSDQ:ARAY) have risen today after the medical device maker beat expectations on Wall Street with its 2nd quarter earnings results. The Sunnyvale, Calif.-based company posted losses of $4.7 million, or 6¢ per share, on sales of $100.3 million, seeing losses shrink 49.6% while sales grew 14.7% compared with the same period during the prior year. Losses per share were just ahead of the 10¢ consensus on Wall Street. “We have made solid progress towards achieving consistent operating performance during the first half of the fiscal year and we believe we are well on track to achieve our fi...
Source: Mass Device - January 24, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Accuray Inc. Source Type: news

ScandiDos brings Delta4 Discover to U.S. market
Swedish radiation therapy quality assurance firm ScandiDos has received the...Read more on AuntMinnie.comRelated Reading: ScandiDos prepares new QA system for ASTRO 2016 FDA clears ScandiDos dosimetry system ScandiDos readies in vivo dosimetry system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 24, 2018 Category: Radiology Source Type: news

In Esophageal Cancer, Lung Radiation Dose Affects Survival In Esophageal Cancer, Lung Radiation Dose Affects Survival
Is decreased survival from radiation therapy to adjacent lung tissue caused by toxicity, or is it due to'unintended consequences'?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

The Road to Meaningful Global Radiotherapy Access The Road to Meaningful Global Radiotherapy Access
About 30 countries in Africa do not have any radiotherapy units. Lack of access to radiation therapy is a sobering reality for patients with cancer in low- and middle-income countries.Journal of Global Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 16, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

BioProtect wins FDA IDE nod for ProSpace trial
Oncology device developer BioProtect said today it won FDA investigational device exemption approval to launch a pivotal clinical study of its ProSpace balloon system designed to prevent rectal toxicity following prostate cancer radiotherapy. The ProSpace balloon system is a novel balloon spacer designed to temporarily separate the rectum from the prostate during prostate cancer radiation therapy to reduce rectal radiation exposure. The Israel-based company said it plans to launch a prospective, randomized study to explore the safety and effectiveness of the ProSpace spacer to protect the rectum and lower GI trac...
Source: Mass Device - January 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Oncology Regulatory/Compliance BioProtect Source Type: news

Varian pursues partnership in China
Varian Medical Systems has signed a memorandum of understanding with healthcare...Read more on AuntMinnie.comRelated Reading: Taiwan clears Varian's radiation therapy system Varian's Halcyon receives Brazilian market clearance Oncology Services installs Varian radiotherapy system Varian opens new regional center in Brazil Varian secures Japanese clearance for Halcyon (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 9, 2018 Category: Radiology Source Type: news

An Update on Radiation Therapy for Brain Metastases An Update on Radiation Therapy for Brain Metastases
Recent advances in radiotherapy for brain metastases are preserving neurocognitive function without compromising survival.Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 9, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Varian inks Chinese cancer care deal with Ping An, wins Taiwanese nod for Halcyon
Varian Medical (NYSE:VAR) said today it signed a strategic partnership deal with Ping An Health Technology to explore expanding cancer care in China, and that it won Taiwanese approval for its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system. In its deal with Ping An, Palo Alto, Calif.-based Varian said both companies will explore using artificial intelligence, cloud computing and big data tech to bring high quality, cost-effective cancer care to more individuals in China. “We are pleased to be collaborating with Ping An, the leading force in the field of healthc...
Source: Mass Device - January 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology Regulatory/Compliance Varian Medical Systems Source Type: news

Taiwan clears Varian's radiation therapy system
Varian Medical Systems' Halcyon radiation therapy system has received clearance...Read more on AuntMinnie.comRelated Reading: Varian's Halcyon receives Brazilian market clearance Oncology Services installs Varian radiotherapy system Varian opens new regional center in Brazil Varian secures Japanese clearance for Halcyon Varian names new chief people officer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 8, 2018 Category: Radiology Source Type: news

One in Five Limited-Stage SCLC Patients Get No Treatment (CME/CE)
(MedPage Today) -- Federally insured patients less likely to get radiation therapy (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - January 5, 2018 Category: Radiology Source Type: news

Radiation therapy algorithm could reduce side effects, maintain effect against tumors
(North Carolina State University) A mathematical model for computing radiation therapy treatments could substantially reduce patient side effects while delivering the same results as conventional radiation therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 5, 2018 Category: International Medicine & Public Health Source Type: news

Antioxidant power: Blueberry extract found to improve health outcomes for women receiving radiation for cervical cancer, reducing the damaging effects of the therapy
(Natural News) The extract of blueberry, which is a known superfood, can be beneficial to cervical cancer patients that undergo radiation therapy, according to a study. In the United States, there are about 12,000 women who are diagnosed with cervical cancer. Furthermore, this type of cancer is the fourth most common cancer in women with... (Source: NaturalNews.com)
Source: NaturalNews.com - January 4, 2018 Category: Consumer Health News Source Type: news

Medical News Today: How blueberries help to kill cancer cells
Researchers suggest that the success of radiation therapy against cancer cells could be increased significantly, thanks to blueberries. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 3, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Berry gives boost to cervical cancer therapy
According to the Centers for Disease Control and Prevention, approximately 12,000 women in the United States are diagnosed with cervical cancer each year. One of the most common treatments for cervical cancer is radiation. While radiation therapy destroys cancer cells, it also destroys nearby healthy cells. University of Missouri School of Medicine researchers studied in vitro human cancer cells to show that combining blueberry extract with radiation can increase the treatment's effectiveness. (Source: World Pharma News)
Source: World Pharma News - December 29, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Berry gives boost to cervical cancer therapy
(University of Missouri-Columbia) According to the Centers for Disease Control and Prevention, approximately 12,000 women in the United States are diagnosed with cervical cancer each year. One of the most common treatments for cervical cancer is radiation. While radiation therapy destroys cancer cells, it also destroys nearby healthy cells. University of Missouri School of Medicine researchers studied in vitro human cancer cells to show that combining blueberry extract with radiation can increase the treatment's effectiveness. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 29, 2017 Category: Cancer & Oncology Source Type: news

FDA clears Xcision Medical ’ s GammaPod breast cancer device
The FDA said today that it granted 510(k) clearance to the GammaPod stereotactic radiotherapy device made by Xcision Medical Systems to treat breast cancer. The federal safety watchdog said the GammaPod is designed to treat a portion of the breast in conjunction with breast-conserving surgery. It uses an array of 36 Cobalt-60 sources to beam radiation from within a two-layer vacuum cup that immobilizes the breast to minimize damage to adjacent healthy tissue. GammaPod is not intended to replace whole-breast radiation therapy and has not been shown to be as effective as that technique, the FDA said. The clearance was b...
Source: Mass Device - December 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Radiosurgery Regulatory/Compliance xcisionmedicalsystems Source Type: news

New measurements to guide radiation therapy
(American Institute of Physics) When ionizing radiation passes through living tissue, it interacts with molecules present in the cells, stripping away electrons and producing charged species known as ions. The electrons produced by this process, known as secondary electrons, can themselves go on to wreak further havoc, causing even more dramatic changes. This week in The Journal of Chemical Physics, investigators report studies of the impact of secondary electrons on a model of DNA. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 19, 2017 Category: International Medicine & Public Health Source Type: news

UNC Lineberger awarded $11.9M grant to study radiation treatments for prostate cancer
(UNC Lineberger Comprehensive Cancer Center) The Patient-Centered Outcomes Research Institute has awarded UNC Lineberger Comprehensive Cancer Center's Ronald C. Chen, MD, MPH, a five-year, nearly $12 million grant to fund a comparative study of intensity-modulated radiation therapy and proton beam for prostate cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 18, 2017 Category: Cancer & Oncology Source Type: news

UNC Lineberger awarded $11.9 million grant to study radiation treatments for prostate cancer
(UNC Lineberger Comprehensive Cancer Center) The Patient-Centered Outcomes Research Institute has awarded UNC Lineberger Comprehensive Cancer Center's Ronald C. Chen, MD, MPH, a five-year, nearly $12 million grant to fund a comparative study of intensity-modulated radiation therapy and proton beam for prostate cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 18, 2017 Category: International Medicine & Public Health Source Type: news

2017 Medtech Company of the Year: Readers & #039; Choice
Each year, MD+DI’s editors gather to choose which company should be named the Medtech Company of the Year, and it’s always a heated debate. This year, we named nine finalists, but the decision to crown Abbott as our 2017 Medtech Company of the Year was unanimous. Our readers, however, had a different opinion. While MD+DI’s editors chose Abbott for its ability to rise above challenges, Bigfoot Biomedical was the favorite among our readership. The Milpitas, CA-based firm is amalgamating other companies’ hardware plus its own software and algorithms to craft an artificial pancreas for patients with dia...
Source: MDDI - December 16, 2017 Category: Medical Devices Authors: Jamie Hartford Tags: Business Source Type: news

Women not getting recommended breast radiation therapy
Almost 10% of women don't receive radiation therapy after breast conservation...Read more on AuntMinnie.comRelated Reading: ASTRO: Breast radiation 'less scary' than expected JCO releases new sentinel node biopsy guidelines ASTRO: Radiation boost cuts local recurrence in DCIS patients Choosing Wisely boosts use of short-course breast radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2017 Category: Radiology Source Type: news

Oncology Services receives another ISO certification
Radiation therapy service firm Oncology Services International has obtained...Read more on AuntMinnie.comRelated Reading: Oncology Services installs Varian radiotherapy system Consensys teams with rad therapy firm Oncology Services gets ISO recertification Oncology Services International names CEO OSI revenues grew in Q2 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 13, 2017 Category: Radiology Source Type: news

Elekta taps Brainlab as US stereotactic neurosurgery distro partner
Elekta (STO:EKTA B) said today it inked an exclusive deal with Brainlab to make it the authorized distributor of Elekta’s stereotactic neurosurgery solutions. Through the deal, Brainlab will be the authorized distributor of Elekta’s Leksell Vantage stereotactic system which won CE Mark approval in the European Union this year. The system also has FDA 510(k) clearance and is commercially available in the US. Stereotactic neurosurgery is a minimally invasive approach to brain surgery designed to treat specific regions of the brain and spare surrounding healthy tissue, and is often used to implant deep brain ...
Source: Mass Device - December 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Neurological Brainlab Elekta Source Type: news

Combination of Immunotherapy and Radiation Therapy in NSCLC Combination of Immunotherapy and Radiation Therapy in NSCLC
Review the rationale and preclinical evidence for combining radiation and immunotherapy in NSCLC.Translational Lung Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Glioblastoma survival mechanism reveals new therapeutic target
(Northwestern University) A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2017 Category: Cancer & Oncology Source Type: news

iCAD touts study on radiation therapy savings
Computer-aided detection developer iCAD is touting a study that found intraoperative...Read more on AuntMinnie.comRelated Reading: iCAD scores Chinese OK for balloon applicators iCAD to highlight Xoft clinical results at AAPM iCAD system treats 1st patient in Australia iCAD to highlight Xoft clinical results at ABS FDA OK's iCAD tomosynthesis software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 8, 2017 Category: Radiology Source Type: news

Varian's Halcyon receives Brazilian market clearance
Varian Medical Systems' Halcyon radiation therapy system has received clearance...Read more on AuntMinnie.comRelated Reading: Oncology Services installs Varian radiotherapy system Varian opens new regional center in Brazil Varian secures Japanese clearance for Halcyon Varian names new chief people officer Varian's fiscal 2017 results hold steady (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 6, 2017 Category: Radiology Source Type: news

Distrust In Health-Care System Might Prevent Breast Cancer Patients From Getting Recommended Care
Breast cancer patients who said they didn't trust the health-care system were less likely to get follow-up chemotherapy or hormonal or radiation therapy as recommended by their physician after their initial treatment. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 30, 2017 Category: Pharmaceuticals Authors: Rita Rubin, Contributor Source Type: news

Elekta delays rollout for Unity MR-radiation therapy combo
Elekta (STO:EKTA B) today said it’s delaying the rollout of its Unity device, designed to combine magnetic resonance imaging with a linear accelerator for radiation therapy, saying it needs more time to finalize and validate the linac control system. The Swedish company said the decision means it’s postponing its bid for CE Mark approval in the European Union until the first half of next year. “We are convinced that the new technology will revolutionize radiation therapy and create completely new opportunities for physicians and their patients. With the shift in CE Mark and FDA submission, we adjust ...
Source: Mass Device - November 30, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Imaging MassDevice Earnings Roundup Radiosurgery Wall Street Beat Elekta Source Type: news

Sharing Mayo Clinic: Throat cancer treatment gives dentist new perspective
After undergoing robotic surgery, radiation therapy and chemotherapy as part of a clinical trial to treat cancer, Bruce Trulson has gained a new understanding of how he can better care for his own patients. In 2015, after nearly 40 years of practicing dentistry, Bruce Trulson, D.D.S., gained new insight into how to care for his [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 26, 2017 Category: Databases & Libraries Source Type: news

Ludwig researchers unravel novel mechanism by which tumors grow resistant to radiotherapy
(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 23, 2017 Category: International Medicine & Public Health Source Type: news

Whole Pelvic Radiation, ADT Limit Prostate Cancer Biochemical Failure Whole Pelvic Radiation, ADT Limit Prostate Cancer Biochemical Failure
Whole pelvic radiation therapy (WPRT) and androgen deprivation therapy (ADT) reduce the risk of biochemical failure in men who receive post-prostatectomy salvage radiotherapy for prostate cancer, according to a database study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 22, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Children undergoing radiation for cancer may have alternative to sedation
(University of North Texas) Radiation therapy for children with cancer is painless, but preparation for it may cause great stress for a child and his or her family because the child is routinely sedated before each treatment, to stay motionless. Manish Vaidya at the University of North Texas is using a computer program to train young patients to stay motionless so sedation won't be necessary. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news